CN-640000-12007-A2.pdf

This document is a Second Amendment to a Laboratory Testing Services Contract between Quest Diagnostics Clinical Laboratories, Inc. and the State of Florida, Department of Health. The amendment was executed on May 23, 2013, following an initial agreement from February 4, 2013, and a previous first amendment from February 26, 2013.

The amendment addresses the addition of new laboratory testing services not originally listed in the contract's scope. Quest Diagnostics will price these new tests consistent with the existing agreement's terms, using Core Test pricing and applying Balance of Line 20% discounts. The amendment specifically adds two additional tests for MMR and Anal Pap testing by Department facilities, with specific test code changes including Panel-Measles, Mumps, Rubella-S29, and Cytopath-NonGyn Fluid-$45. The parties agree to quarterly review and potential amendment of the test list, with new tests to be priced comparably to existing Core Tests and discounted similarly to Balance of Line tests.